News

Olympia Pharmaceuticals | 503B Outsourcer | 503A Compounding Pharmacy

Market 50/100How we got 50/100Source tierUnclassified sourceTier ceiling50/100Independent sourcesnot recordedPublished score50/100Scored at the ceiling for a unclassified source source — it cannot go higher. The number is the source page’s own score, hard-capped at the tier ceiling; corroboration is recorded but cannot lift a score past that cap. Under 40 a claim goes to review instead of publication. Full methodology →
July 28, 2026↗ source

Olympia Pharmaceuticals is promoting its services as a 503B FDA-registered outsourcing facility and affiliated 503A compounding pharmacy. The company markets a variety of injectable therapies, including weight management and peptide treatments, emphasizing regulatory compliance and nationwide shipping capabilities for clinics and patients.

Related peptides

GLP-1C-peptideLongevityPeptide TGLP-1 Agonists
We summarize, we don't invent — every detail here traces to a real, linked source, and the badge reflects how trustworthy that source is. Read the original and decide for yourself.